Search
for
Sort by
Research 391–420 of 1000+
- Case number 19th of perforating necrobiosislipoidica worldwide
- Relationship between glucose homeostatic disorders and testosterone in adult Nigerian women with polycystic ovary syndrome
- Endocrinopathies, Atypical
- 268 Male-pattern baldness and its association with coronary heart disease
- Necrolytic Migratory Erythema in a Cat with Glucagonoma Syndrome
- A clinicopathologic study of lichen planopilaris among men
- Hair Loss and It’s Homeopathic Approach
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- Medical and Surgical Hair Restoration
- Pathologies of the skin and its appendages in endocrine diseases
- History and physical examination of polycystic ovary syndrome: Detecting too much or too little
- Workup and Management of Polycystic Ovary Syndrome
- Lab Quality Management and Methodology
- Hair Growth Defects of Diabetic and Hypercholesterolemic Wistar Albino Rats and Amelioration of Fish Oil-Treatment
- Complications and Difficult Cases: A Case Report of Central Area Necrosis Following a Hair Transplant Procedure
- Drug-induced diffuse hair loss in females: An observational study
- News and Reviews
- Prevalance, clinical features and evaluation of the risk factors for onychocriptosis in adult diabetic patients in outpatient clinic
- Severe Insulin Resistance in a Pediatric Patient: Key Areas to Address in the Screening
- Acne Vulgaris Associated with Polycystic Ovary Syndrome (Pcos)
- Psoriasis and psoriatic arthritis patient productivity burden in the United States
- Egr-1 is main key regulator in IL-17F-induced psoriasin expression in human keratinocytes
- Prevalence of autoimmune diseases and other comorbidities in patients with psoriasis in the United States
- Clinical Evaluation and Therapeutic Outcome in Hirsutism
- Alopecia androgenética en varones jóvenes: un indicador clínico temprano de resistencia a la insulina
- The polycystic ovary syndrome
- NEW PROPRIETARY BRANDS: Gabapentin
- New drugs: Iobenguane sulfate
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta